PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 2026Biomacromolecules0 citations

Polymerized Polyphenol-Decorated Cationic Hydroxyethylcellulose Nanocomplexes for Enhanced Breast Cancer Cell Killing Effects

View Full Paper
SPSeoyeon ParkTKTae-il Kim

Key Points

  • This research aims to develop multifunctional nanocomplexes for targeted delivery of drugs and genes to breast cancer cells.
  • Developed epigallocatechin gallate (EG) nanocomplexes using cationic hydroxyethyl cellulose (HEC)
  • Synthesis of pPBA-EG polymer and assembly with doxorubicin (Dox) and Bcl-2 siRNA
  • Evaluated cellular uptake and anticancer effects in MDA-MB-231 cells
  • Significant downregulation of Bcl-2 and upregulation of FAS indicating apoptosis-mediated cell death
  • High transfection efficiency and enhanced stability of EG in the nanocomplexes
  • Effective cell killing observed even in Dox-resistant MDA-MB-231 cells

Abstract

In this study, epigallocatechin gallate (EG)-containing multifunctional nanocomplexes based on cationic hydroxyethyl cellulose (HEC) were developed for breast cancer–targeted drug/gene codelivery. The pPBA-EG polymer was synthesized by grafting EG–phenylboronic acid (PBA) conjugates onto a poly(methyl vinyl ether-alt-maleic anhydride) (pMVMA) backbone, and combined with polyethylenimine 2k–modified hydroxyethyl cellulose (HECP2k) to deliver doxorubicin (Dox) and Bcl-2 siRNA, maintaining high transfection efficiency while enhancing EG stability and functionality. The resulting pPBA-EG/HECP2k@Dox/siRNA nanocomplexes exhibited suitable nanoscale size, positive surface charge, and efficient nucleic acid condensation. Enhanced cellular uptake via sialic acid interactions of the nanocomplexes was observed in MDA-MB-231 cells, leading to strong anticancer effects even in Dox-resistant cancer cells. Significant Bcl-2 downregulation and FAS upregulation indicated apoptosis-mediated cell death. These findings suggest that pPBA-EG/HECP2k@Dox/siRNA nanocomplexes present a promising strategy for concurrent delivery of siRNA, Dox, and EG, enhancing therapeutic potential against sialic acid-overexpressing breast cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Park et al. (2026) studied this question.

synapsesocial.com/papers/6a1bd1db5783ba022b6fd3d9https://doi.org/10.1021/acs.biomac.6c00303
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Polyphenol-assisted facile assembly of bioactive nanoparticles for targeted therapy of heart diseases2021 · 52 citations
  2. 2HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer2024 · 11 citations
  3. 3The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly2018 · 17 citations
  4. 4Synthesis and bioactivity of a conjugate composed of green tea catechins and hyaluronic acid2015 · 48 citations
  5. 5Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells2000 · 35 citations